The Future of Asthma Medications and Treatments - WebMD
2022年11月12日 · There are a few newer types of treatment that you can use for certain types of asthma. If you use an inhaler and still have problems with your asthma, biologic therapy targets different parts...
New Medications and Treatments for Severe Asthma - Healthline
2024年2月27日 · New treatments for severe asthma may include biologics, surgical techniques, and leukotriene modifiers, among others. Researchers are still searching for new drugs to prevent and relieve...
FDA approves drug combination treatment for adults with asthma
2023年1月11日 · FDA has approved Airsupra (albuterol and budesonide) inhalation aerosol for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of asthma attacks in...
FDA Approves AIRSUPRA, a New Quick-Relief Medicine for Adults …
AIRSUPRA is a first-in-class, pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide, an anti-inflammatory inhaled corticosteroid (ICS) in the US. It …
List of 57 Asthma Medications Compared - Drugs.com
Compare risks and benefits of common medications used for Asthma. Find the most popular drugs, view ratings and user reviews.
First new asthma attack treatment in 50 years - BBC News
2024年11月28日 · Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the immune system that can go into overdrive in flare-ups of both...
Scientists Develop Whole New Form of Effective Asthma Treatment
2024年11月28日 · The already-approved drug for asthma could replace steroid medications as a means of quelling asthma and COPD flare-ups, researchers report. Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, breathlessness and hacking up phlegm, according to trial results published in ...
FDA APPROVES TEZSPIRE™ (TEZEPELUMAB-EKKO) IN THE U.S. FOR SEVERE ASTHMA
2021年12月17日 · Tezspire is a first-in-class medicine indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Tezspire is not indicated for the relief of acute bronchospasm or status asthmaticus. Known hypersensitivity to tezepelumab-ekko or excipients.
“Game-Changing” New Treatment for Asthma Could Save
2024年12月3日 · A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment failures and improving quality of life. This breakthrough marks a significant advancement after 50 years of stagnant treatment options.
TEZSPIRE Now Available in the United States for the Treatment of …
2022年1月13日 · New Biologic Therapy Available for Broad Population of Severe Asthma Patients Without Phenotype or Biomarker Limitations. WILMINGTON, Del., January 13, 2022 – AstraZeneca and Amgen today announced TEZSPIRE™ (tezepelumab-ekko) is now available for shipment to wholesalers in the US.